A trial fibrillation (AF) has a significant public health burden and conveys profound morbidity and mortality. AF is largely a disease of advancing age because risk doubles with each progressive decade of gaining and exceeds 20% by age 80 years.
AF, Physical Performance, and Older Adults frailty syndrome 6 -a complex and dynamic clinical syndrome marking progressive functional decline 7, 8 -have not been well established.
We sought to identify the associations of AF and prospective decline in physical performance in the Health, Aging, and Body Composition Study (Health ABC) . The associations of AF and insults in aging-silent cerebral infarcts, diastolic and systolic heart failure, decreased exertional stamina, and others-may contribute to decline in physical performance. We hypothesized that AF would exacerbate progressive decline in physical performance measured in this community-based cohort of older adults.
Methods

Study Cohort
Health ABC is a longitudinal study of community-dwelling, older adults designed to examine aging-related health outcomes. 9, 10 Cohort participants were recruited by randomly sampling white and all black Medicare beneficiaries around Memphis, Tennessee, and Pittsburgh, Pennsylvania. Eligibility criteria included age 70 to 79 years, white or black race, and well functioning, defined as not having difficulty walking a quarter mile, climbing a flight of stairs, and performing activities of daily living without assistance. Study participants underwent the initial, baseline examination in 1997-98 (n=3075; 52% women, 42% black race) followed by 6-month interim telephone contacts with annual examinations through year 6 and then at years 8 and 10. Examinations included standardized assessments (interview, interim history and medications, physical examination and anthropometry, motor and cognitive testing, and blood tests). The present study used data from the baseline examination and years 4, 6, 8, and 10 .
The present analysis excluded participants lacking Center for Medicare and Medicaid Services (CMS) data (n=36) pertinent to AF status, with prevalent AF at the Health ABC baseline visit identified by CMS coding (n=128), missing follow-up assessments of physical function (n=3), or lacking covariates (n=155). Health ABC study protocols were approved by Institutional Review Boards at the University of Tennessee and the University of Pittsburgh, and participants provided informed consent at all study visits.
Determination of Incident Atrial Fibrillation in Health ABC
Incident AF was obtained by linkage of unique participant identifiers with the CMS database. 11 CMS data were obtained from the baseline examination through 10 years. Individuals with International Classification of Diseases, Ninth Revision, codes 427.31 or 427.32 from either a single inpatient or 2 outpatient claims within 365 days were identified as having AF. The use of 2 outpatient claims has been reported as improving diagnostic specificity. 11, 12 The earliest date of International Classification of Diseases, Ninth Revision, coding assignment was deemed the date of incident AF. Participant electrocardiograms or hospital records pertinent to identifying AF were not available for review; AF is not an adjudicated study end point in Health ABC. Ascertainment of AF using International Classification of Diseases, Ninth Revision, coding has been reported to have 84% sensitivity and 98% specificity for AF identification. 13 Duration of AF was determined from the date of incident AF to the date of subsequent examinations.
Physical Performance Assessment in Health ABC
A primary objective of Health ABC is to examine changes in physical performance in older adults concomitant with aging. The Health ABC physical performance battery (PPB) combines measures modified from the lower extremity performance tests used in the Established Populations for the Epidemiological Studies of the Elderly battery 14 and is well validated for the repeated measure of physical performance in older adults. 15, 16 The Health ABC PPB is determined from (1) standing balance, assessed by 30 seconds in the semi-tandem, tandem, and one-leg stands; (2) chair stands, measured as the time to rise 5 times unassisted from a seated position; (3) gait speed, time to walk 6 m at usual pace; and (4) a narrow walk balance test using a 6-m long, 20-cm wide path for balance assessment. The methods for conducting the PPB assessments and their baseline distributions in Health ABC have been previously detailed. 9, 15 Scoring of the Health ABC PPB ranges continuously from 0 to 4, where a higher score indicates superior performance.
Measures in addition to the PPB comprised hand grip strength, 2-minute walking distance, and time to complete a 400-m walk. Grip strength was performed using a Jamar Hydraulic Hand Dynamometer (Sammons-Preston, Jackson, MI) in 2 trials of both hands. Participants were excluded for wrist or hand pain and upper-extremity procedure in the 3 months before testing. Walking assessments were conducted by completion of the 2-minute walk, 30-second pause, and then the timed 400-m walk. Participants were instructed to walk as far as possible during the 2-minute walk and to complete the 400-m walk as quickly as possible at a pace they could maintain. Participants were excluded from the walking test for having systolic blood pressure >199 mm Hg, diastolic blood pressure >109 mm Hg, resting heart rate <40 or >110 beats per minute, or specified electrocardiographic abnormalities (preexcitation, idioventricular rhythm, ventricular tachycardia, third degree or complete heart block, or evidence of acute injury, ischemia, or marked T-wave abnormality). The Health ABC PPB was performed at baseline and examination years 4, 6, and 10. The remaining physical performance assessments were performed at these years and examination year 8.
Baseline Study Measurements and Interim Events
Race (black or white) and smoking status (current/former or never) were determined by self-report. Moderate-to-heavy alcohol
WHAT IS KNOWN
• Studies have related atrial fibrillation (AF) and reduced physical function, but most investigations have not included adults beyond the eighth decade, the age group at highest risk for both AF and decline in physical performance.
• Decline in physical performance in older adults is an important marker of increased risk of cardiovascular and noncardiovascular morbidity and mortality.
WHAT THE STUDY ADDS
• In this study of community-dwelling older adults, participants with AF experienced a greater 4-year decline in physical performance across multiple measures than those without AF.
• The study demonstrates that AF contributes toward the multisystem decline in physical performance as part of aging-related pathophysiology.
• The study expands our understanding of the insults associated with AF, and raises the hypothesis that interventions may attenuate the contribution of AF toward the decline in physical strength and performance in vulnerable older adults.
consumption was defined as men consuming ≥14 drinks weekly and women ≥7 drinks weekly. Body mass index was calculated as weight divided by height squared (kg/m 2 ). Systolic and diastolic blood pressures were determined from the average of 2 measurements obtained in a seated position. Hypertension was determined by self-report and initiation of new antihypertensive medication. Diabetes mellitus was ascertained from self-reported history, fasting glucose ≥126 mg/dL, or use of oral hypoglycemic or insulin medications. Blood samples were assayed for serum creatinine and after an 8-hour fast for total and high-density lipoprotein cholesterol measures (OrthoClinical Diagnostics, Rochester, NY). Abnormal cholesterol was defined as total cholesterol ≥200 or high-density lipoprotein <40 mg/ dL. Medications were classified using the Iowa Drug Information System. Prevalent cardiovascular disease was defined in Health ABC as including coronary artery disease (determined by angioplasty, bypass graft, myocardial infarction, or ECG showing a major Q-wave abnormality) and stroke by self-report and review of medications. Prevalent heart failure was established by self-report or medications.
Interim covariates were incident hypertension, diabetes mellitus, cardiovascular disease, and cancer. Incident cardiovascular disease was defined as hospitalization for myocardial infarction or angina, stroke, or congestive heart failure with overnight hospitalization, as determined by report or documentation and adjudicated as previously detailed. [17] [18] [19] Incident cancer was determined by malignancy history (excluding melanoma) and after adjudication of a cancer diagnosis. 20 Interim incident covariates were ascertained at annual examinations or 6-month telephone contacts with Health ABC participants or their proxies. Deaths were identified using obituaries, the Social Security Death Index, or telephone contact with participant representative; death certificates, interviews with next of kin, and hospital records were reviewed by the study's Diagnosis and Disease Ascertainment Committee to adjudicate cause of death. Follow-up duration was determined from the baseline visit through 10 years with censoring at the date of death or last known study contact.
Statistical Analyses
We examined categorical variables for their distributions and continuous variables for their mean and standard deviations. We examined Health ABC PPB and additional measures of physical performance (grip strength, walking distance, and time to complete a 400-m walk) and their 4-year decline in HABC participants with and without incident AF. We used a mixed-effects model using a random intercept and slope of age. Age was considered a time-varying variable. We developed models to estimate the 4-year decline at ages 70, 74, 78, and 82 years for each of the physical performance assessments. We determined interactions by examining the statistical significance of interaction terms. Specifically, we examined the fixed effect of age and then examined statistical interaction terms to determine effect modification by sex, race, study site, body mass index, systolic and diastolic blood pressure, smoking, alcohol use, cholesterol, and creatinine. We used fixed effects on age, the product of age×AF duration, age×incident AF, and age2 (centered at 74 years). The initial model (Model 1) was adjusted for baseline age, sex, race, study site, and the interaction of age×sex. Model 2 included all Model 1 covariates and additionally adjusted for body mass index, systolic and diastolic blood pressure, smoking, moderate/heavy alcohol use, cholesterol, creatinine, and interactions of age×body mass index and age×creatinine, and the following covariates as time-varying exposures: hypertension, diabetes mellitus, cardiovascular disease, and cancer. Models examining grip strength, walking distance, and 400-m walk time were constructed using the same random effects as the 4-year decline in Health ABC PPB. All statistical analyses were conducted using SAS version 9.3 (SAS Institute, Cary, NC). A 2-sided P<0.01 was deemed statistically significant.
Results
Following exclusions, the analysis consisted in 2753 Health ABC participants (52% women, 41% black race; Table 1 ). Many study participants had risk factors for AF (mean body mass index in the overweight range; prevalence of current/ former smoking, 56%; hypertension, 39%; and diabetes mellitus, 39%). Over the 10-year follow-up, 262 participants both developed AF and had subsequent physical performance assessments. Table 2 summarizes participation, AF status, and the number of participants completing physical performance assessments across examination years. Table I in the onlineonly Data Supplement presents the distributions of assessments across Health ABC participants at ages 70, 74, 78, and 82 years.
The estimates of 4-year declines in Health ABC PPB scores at ages 70, 74, 78, and 82 years are shown in Table 3 . The table presents the mean estimated 4-year decline in Health ABC PPB scores in participants without AF, those with AF, and the difference in PPB decline between those with and without AF at the specified age. Participants with AF at each of the 4-year age categories had significantly greater decline in Health ABC PPB compared with those without AF. For instance, at age 70 in the multivariable and interim-adjusted model 3, those without AF had a PPB decline of 0.20, whereas those with AF had a decline of 0.28 for an absolute difference in decline of 0.08. The decline in PPB in participants with AF was accelerated by ≈4 years compared with those without AF. This significantly accelerated decline in PPB in participants with AF compared with those without remained Continuous variables expressed as mean±SD, categorical variables as n (%). PPB indicates physical performance battery. AF, Physical Performance, and Older Adults present after adjustment for baseline and time-varying covariates. Figure 1 presents the differences in the estimates of PPB decline across progressive 4-year age categories graphically. The figure demonstrates distinct trajectories of Health ABC PPB decline between participants with and without AF from age 70 years onwards. Table 4 describes the estimates for 4-year decline in grip strength with and without incident AF at ages 70, 74, 78, and 82 years. Similar to the PPB estimates, participants with AF had a significantly greater grip strength decline relative to those without. The decline remained significant across age group and progressive multivariable adjustment. Likewise, Table 5 presents the differences in 2-minute walking distance and 400-m walking time. Like the other measures, there are progressive declines in 2-minute walking distance and 400-m walk time with aging, but those with AF have a significantly greater 4-year decrease compared with those without.
Discussion
In a community-based, biracial cohort of older adults, we observed that participants with AF had a significantly higher 4-year decline in physical performance compared with those without AF. The results reported here were consistent for each measure used in Health ABC to evaluate physical performance (including PPB, grip strength, 2-minute walking distance, and 400-m walk time). The accelerated decline in physical performance with AF was not substantively attenuated by comorbidities, such as stroke, congestive heart failure, cancer, and noncardiac diseases associated with morbidity in older adults. Figure 1 summarizes the accelerated, progressive decline of physical performance in cohort participants with AF.
Health ABC enrolled community-dwelling older adults with a primary objective of studying determinants of the onset of mobility impairment and, hence, is an important opportunity to examine the relations of AF with physical performance in healthy older adults.
Small changes in physical function in older adults have been shown to be clinically meaningful, 21 particularly because of the relation of decline in physical function to clinical events. Our work describes the modest but important associations between AF and progressive decline in physical performance in Health ABC participants. For example, PPB is measured continuously from 0 to 4, and a 4-year decline of 0.12 has been determined as a meaningful change in physical function. 22 We identified that cohort participants with AF experience an additional decline of 0.10 (95% CI 0.18-0.01) at age 82 after accounting for relevant covariates. Model 1, adjusted baseline age, sex, race, site, and interaction of age-by-female. Model 2, additionally adjusted on baseline BMI, SBP, DBP, smoking, moderate/ heavy drinking, abnormal cholesterol, creatinine, and interactions of age with BMI and creatinine and for hypertension, diabetes mellitus, cardiovascular disease, and cancer as time-varying covariates. BMI indicates body mass index; DBP, diastolic blood pressure; Est, estimate; Health ABC, Health Aging, and Body Composition; and SBP, systolic blood pressure.
*Health ABC physical performance battery, scored 0-4, used as a continuous measure. †Difference is the difference in 4-year physical function decline between Health ABC participants with and without incident AF at the specified age. AF, Physical Performance, and Older Adults
In the Context of the Literature
The literature has documented the relations of physical performance measures and adverse outcomes in older adults. Subtle changes may contribute toward adverse outcomes in older adults. Gait speed-a highly reproducible measure, central to the Health ABC PPB and integral to 2-minute distance and 400-m walk time-has been associated with prospective disability, loss of capacity for activities of daily living, cognitive decline, dementia, institutionalization, and mortality. [23] [24] [25] [26] Chair stands, also part of the Health ABC PPB, have similarly been associated with disability and mortality in Health ABC participants. 27 Hand grip strength has been associated with prospective disability 28 and functional decline 29 and is a core measure for assessing frailty, in turn related to cardiovascular outcomes. [30] [31] [32] In our analysis, AF was related to 2 of the proposed criteria for frailty 33 -reduced grip strength and slower walking speed. A robust literature has confirmed the clinical importance of the assessments of physical performance performed here. Our findings support the hypothesis that AF contributes toward degenerative processes of physical performance in aging.
The relation of AF and physical function has had repeated assessments in community-based studies and clinical trials. 34 In general, the literature has been challenged by limited inclusion of adults beyond the eighth decade. Prior investigations examining AF and frailty in older adults remain limited. A cross-sectional study of community-dwelling older adults, younger than Health ABC, identified an association between AF and reduced gait speed, 35 but did not assess the prospective relation of AF to gait speed decline. Studies of hospitalized patients have reported increased disability and frailty in older adults with AF, but relied on self-reported disability and did not use a validated definition of frailty. 36, 37 Perception of frailty has been reported as a fall risk in anticoagulation for stroke prevention in AF, 38 but again not using validated criteria for frailty. Our analyses extend these prior findings that AF is associated with a decline in physical performance in aging and underscore the importance of more formal evaluations of the contributions of AF toward frailty and longitudinal adversity in aging.
Interrelated Mechanisms of AF and Declining Physical Performance
We posit that the associations between AF and decline in physical performance are interrelated. AF is a clinical syndrome with both cardiovascular and noncardiovascular manifestations. Our analysis adjusted for standard AF risk factors that may relate to diminished physical performance. It is further possible that incident AF is an intermediate outcome resulting from exposures related to physiological decline in aging. Cardiovascular disease, a chief risk factor for AF, is associated with the development of frailty. 39 Obesity and diabetes mellitus merit particular attention for their separate associations with AF and the development of sarcopenia and progression to frailty. 40, 41 Novel risk factors for AF in older adults (eg, hypogonadism 42 ) have also been related to sarcopenia. 43 Subclinical . AF, Physical Performance, and Older Adults cardiovascular disease and inflammation may also be associated with AF and declining physical performance. [44] [45] [46] [47] Silent cerebral infarcts secondary to AF 48 were not accounted for in our analysis and may also affect physical performance in older adults. Essential questions entail investigating the reciprocal associations of sarcopenia and AF; the relation of inflammation to AF in aging; the burden of silent cerebral infarcts; and the association of AF patterns (ie, paroxysmal, persistent, chronic) with physical performance.
AF may also have a more direct contribution toward the decline in physical performance. AF alters atrial structure and performance, modifies atrial refractoriness, reduces atrial transport (systole), and promotes atrial fibrosis. 49 Irregular heart rates diminish left ventricular filling and cardiac output. 50 Structural and electric cardiac remodeling may impair peripheral perfusion and ultimately diminished capacity for activities of daily living. 51, 52 We present a summary of selected clinical pathways for the association between AF and physical function in Figure 2 .
Our analysis has multiple strengths. First, the measures of physical performance were administered in a standardized format. Second, we conducted our study in a cohort of older adults with preserved functional capacity at baseline, enhancing the relevance of our findings for community-dwelling *Walking distance in meters used as a continuous measure. †Difference is the difference in 4-year walking distance decline between Health ABC participants with and without incident AF at the specified age. ‡P<0.01. § P<0.001.
Figure 2.
Proposed relation between atrial fibrillation, loss of physical performance capacity and functional status, and morbidity in older adults. The figure shows proposed pathways relating atrial fibrillation-with augmented risk in older adults with cardiovascular disease and its risk factors-to loss of atrial mechanics and decreased ventricular function. Heart failure, stroke, and decreased atrial function may contribute toward the decline in physical performance as observed in our analysis. Poor physical performance and functional status in older adults have been related to declining mobility, loss of independence, cognitive decline, disability, institutionalization, and increased mortality. AF, Physical Performance, and Older Adults older adults. Third, our baseline age range was 70 to 79 years. As age is the foremost risk factor for both AF and for decline in physical performance, conducting our study in this demographic enhanced the generalizability and relevance of our findings for older adults. Our study has some limitations. Health ABC had selected geographic enrollment, and generalizability to other races, ethnicities, or geographic regions may be limited. Second, our analysis may have limited generalizability to the growing number of older adults with marginally limited physical performance who reside in transitional settings with supportive care. Such individuals may have unrecognized AF and likely experience more accelerated decline in physical performance than the cohort examined here. We expect that our findings likely underestimate the relation of AF to functional decline by selecting a healthier cohort of older adults. Third, comorbidity is highly common in late adulthood, and our analyses accounted only for major comorbid conditions and risk factors. AF and physical performance, both complex phenotypes, have multiple potential physiological pathways. We cannot exclude residual confounding and recognize that unaccounted for comorbidities may affect both risk of AF and decline in physical performance. Silent cerebral infarcts in particular may have an unrecognized role in mediating the relation of AF and decline in physical function. Fourth, AF status was obtained solely from CMS coding with potential for misclassification of AF status. Even more importantly, Health ABC participants may have had incident AF, developed frailty or other comorbidities, and either not attended subsequent exams or been unable to participate in physical performance assessments. Hence, our results are biased by including only those with AF who were able to perform the physical performance assessments. Fifth, our study is observational; no inference can be made about whether AF causes decline in physical performance. Further, our work cannot establish how treatment of AF may limit age-related changes in physical performance or functional decline. Sixth, there may be nonrandom missing data. Health ABC participants who were ill or who died would not have attended examinations, yet may have had an interim change in physical performance that we did not measure or identify.
Conclusions
We demonstrated that incident AF in independent older adults was associated with significantly greater 4-year decline in physical performance, as determined by validated, clinically relevant measures. We hypothesize that AF is a marker of the frailty syndrome and exacerbates the multisystem decline in physical performance in aging-related pathophysiology. It is possible that AF and physical decline share underlying neuroendocrine or neuromuscular causes. Further research is essential to delineate specific mechanisms relating the onset of AF to decline in physical performance. As well, investigating how training may impact declining physical performance in individuals with AF merits investigation.
